Related by context. All words. (Click for frequent words.) 72 ELACYT 72 Panzem R NCD 72 forodesine 72 elotuzumab 72 atacicept 72 HuMax EGFr 71 PXD# 71 Bezielle 71 vidofludimus 71 alvespimycin 71 Phase IIb clinical trials 71 MGCD# [001] 70 ganetespib 70 CoFactor 70 YONDELIS 70 IRX 2 70 deforolimus 70 PDE4 inhibitor 70 Bicifadine 70 PRT# 70 angiogenesis inhibitor 70 enzastaurin 70 obatoclax 70 HGS# 70 MNTX 69 oral deforolimus 69 oral prodrug 69 methylnaltrexone 69 otelixizumab 69 Symadex 69 EOquin TM 69 PEG SN# 69 ATL# [001] 69 PSMA ADC 69 HGS ETR2 69 phase IIb clinical 69 cilengitide 69 Factor VIIa 69 ulimorelin 69 HuMax CD4 69 Archexin 69 torezolid phosphate 69 ARIKACE ™ 69 Traficet EN 69 CBLC# 69 oral ridaforolimus 69 PNP inhibitor 68 JAK inhibitor 68 mertansine 68 pertuzumab 68 tanespimycin 68 MAXY G# 68 Amigal 68 Viprinex 68 MGd 68 CR# vcMMAE 68 depsipeptide 68 Azedra 68 docetaxel Taxotere R 68 Phase Ib study 68 Menerba 68 IAP inhibitors 68 OXi# 68 belinostat 68 Phase #b/#a 68 teduglutide 68 INCB# [001] 68 BAY #-# 68 liposomal formulation 68 AQ4N 68 oral methylnaltrexone 68 ruxolitinib 68 HGS ETR1 68 indibulin 68 velafermin 68 IIa trial 68 sapacitabine 68 BrachySil TM 67 generation purine nucleoside 67 HuLuc# 67 HuMax CD# 67 velafermin belinostat 67 JAK2 inhibitor 67 SAR# [004] 67 ZOLINZA 67 Neulasta ® 67 Omacetaxine 67 OvaRex ® MAb 67 DXL# 67 NEBIDO 67 CEQ# 67 Plicera 67 Cethrin 67 MAGE A3 ASCI 67 Tamibarotene 67 FOLOTYN ® 67 Guanilib 67 Allovectin 7 67 MEK inhibitor 67 pomalidomide 67 Phase #b/#a clinical 67 ONCASPAR 67 Phase IIb trials 67 Annamycin 67 axitinib 67 bortezomib Velcade 67 AP# [003] 67 Allovectin 7 ® 67 phase IIb trial 67 INCB# [002] 67 voreloxin 67 Proxinium TM 67 Amplimexon 67 ospemifene 67 Sym# 67 Phase IIIb clinical 67 alkylating agent 67 EndoTAG TM -1 67 Phase Ib II 67 thymalfasin 67 Protexia R 67 Octreotide 67 Asentar 67 Neuradiab 67 lomitapide 67 TACI Ig 67 PHX# 67 OMP #M# 67 Amrubicin 67 teriflunomide 67 Apoptone 67 Androxal TM 67 ATL# [002] 67 talactoferrin 66 NP2 Enkephalin 66 midstage clinical 66 apaziquone 66 TOCOSOL Paclitaxel 66 ixabepilone 66 HCD# [002] 66 Personalized Immunotherapy 66 REOLYSIN ® 66 NeuVax 66 nucleoside analog 66 cannabinor 66 Zerenex 66 IMC A# 66 Xanafide 66 Nanobody 66 CYT# 66 anticancer compound 66 Aflibercept 66 Aptivus ® 66 radiation sensitizer 66 dacetuzumab 66 RIGScan CR 66 gemcitabine Gemzar ® 66 PF # [001] 66 Viramidine 66 Onconase 66 phase IIa clinical 66 Panzem R 66 posaconazole 66 Corlux 66 OHR/AVR# 66 Zybrestat 66 Irinotecan 66 receptor tyrosine kinase inhibitor 66 Urocidin 66 FOLOTYN 66 CLORETAZINE TM VNP#M 66 anticancer agent 66 DermaVir Patch 66 SNT MC# 66 ProSavin 66 pradefovir 66 Chemophase 66 Prestara 66 AEG# 66 XmAb# 66 HuMax TAC 66 MEK inhibitors 66 Pimavanserin 66 Targretin 66 LymphoStat B TM 66 ofatumumab 66 selective androgen receptor modulator 66 teplizumab 66 Cellegesic 66 incyclinide 66 PSN# [002] 66 cancer immunotherapies 66 tezampanel 66 Eniluracil 66 CA4P 66 OncoVEX 66 Panzem 66 cetuximab Erbitux 66 oral salmon calcitonin 66 vorinostat 66 L BLP# 66 GRN#L 66 #ME# 66 ASONEP 65 TELINTRA 65 Quinamed 65 registrational 65 Allovectin 7 R 65 valopicitabine 65 targeted radiotherapeutic 65 humanized anti 65 OncoVEX GM CSF 65 bardoxolone 65 confirmatory Phase III 65 GRNVAC1 65 Squalamine 65 AeroLEF TM 65 Dacogen injection 65 Bortezomib 65 ISTODAX 65 Abiraterone acetate 65 erlotinib Tarceva 65 verteporfin 65 tesmilifene 65 IL# PE#QQR 65 huN# DM1 65 subcutaneous formulation 65 Cloretazine ® 65 Hsp# inhibition 65 Civacir 65 pralatrexate 65 Genasense ® oblimersen 65 investigational humanized monoclonal antibody 65 Thiovir 65 orally administered inhibitor 65 pharmacokinetic PK study 65 MAXY alpha 65 Phase IIB 65 tesetaxel 65 Lixivaptan 65 docetaxel Taxotere ® 65 Phase #b/#a trial 65 PEG Interferon lambda 65 IMA# 65 favorable pharmacokinetic profile 65 ENMD # 65 antibody MAb 65 Fodosine 65 sorafenib Nexavar 65 Tavocept 65 lintuzumab 65 pharmacodynamic PD 65 VEGF Trap 65 Talabostat 65 Revlimid lenalidomide 65 lorvotuzumab mertansine 65 SUCCEED trial 65 zanolimumab 65 cetuximab Erbitux R 65 AZILECT ® 65 EGS# 65 Seliciclib 65 Exherin TM 65 MDV# 65 #I TM# 65 tranilast 65 gefitinib Iressa 65 Kamada AAT 65 entinostat 65 Synavive 65 Tyrima 65 Blinatumomab 65 CTCE 65 VAPRISOL 65 Dapagliflozin 65 Phase 2a trial 65 octreotide implant 65 fosbretabulin 65 ONCONASE R 65 anti CD# antibodies 65 GMX# 65 PLK1 SNALP 65 AEGR 65 oral rivaroxaban 65 DAVANAT 65 IMC #B 65 lumiliximab 65 perifosine 65 EVIZON 65 selective modulator 65 KRN# 65 decitabine 65 preclinically 65 Clolar ® 65 phase IIb 65 nitazoxanide 65 mapatumumab 65 celgosivir 65 Potelligent Technology 65 ridaforolimus 65 PKC# 65 epothilone 65 Virulizin ® 65 XL# [003] 65 QLT# 65 rindopepimut 65 JAK1 65 Trastuzumab 65 JAK inhibitors 65 BLA filing 65 rFIXFc 65 Æterna Zentaris 65 Vaxfectin TM 65 CIMZIA TM 65 histone deacetylase inhibitor 65 Cetrorelix 65 IAP inhibitor 65 tremelimumab 65 amrubicin 65 Myocet 65 Phase 1b trial 65 GED aPC 65 subcutaneous SC 65 oxymorphone ER 65 PROSTVAC TM 65 multicenter Phase II 65 BAL# [002] 65 proteasome inhibitor 65 corticosteroid dexamethasone 65 Azedra TM 65 TRO# 65 thetreatment 64 CCR5 mAb 64 trabedersen 64 Laquinimod 64 bicifadine 64 TYZEKA 64 daptomycin 64 Velcade bortezomib 64 CBLB# 64 IV Busulfex 64 MyVax R 64 intranasal formulation 64 atrasentan 64 orally bioavailable 64 oral antiviral 64 ozarelix 64 HQK 64 HSP# inhibitor 64 custirsen 64 romidepsin 64 Harry Palmin President 64 R#/MEM 64 Tesetaxel 64 thalidomide Thalomid 64 GAP #B# 64 Hsp# inhibitor 64 varespladib 64 HCV protease inhibitor 64 PROMACTA 64 DPX Survivac 64 Reolysin 64 Icatibant 64 ritonavir boosted danoprevir 64 Phase IIb III 64 docetaxel chemotherapy 64 Degarelix 64 TRIOLEX 64 tezampanel NGX# 64 vandetanib 64 Curaxin CBLC# 64 Tanespimycin 64 BNC# 64 ularitide 64 XYOTAX TM 64 Aplidin 64 antiangiogenic 64 BRAF inhibitor 64 goserelin 64 AMD# [003] 64 Tezampanel 64 CCX# 64 Maxy G# 64 PEP# [003] 64 PrevOnco ™ 64 Insegia 64 CD# antibody [001] 64 baminercept 64 pan HDAC inhibitor 64 IMGN# 64 sitaxsentan 64 TREANDA 64 tiapamil 64 epigenetic therapies 64 Mipomersen 64 registrational trial 64 PCK# 64 ocrelizumab 64 TRV# [001] 64 nalbuphine ER 64 Ostarine 64 novel VDA molecule 64 BZL# 64 Octreolin 64 Trofex 64 omacetaxine 64 liposomal doxorubicin 64 GRN# 64 CYC# 64 trabectedin 64 adecatumumab 64 trastuzumab DM1 T DM1 64 RG# [001] 64 EOquin 64 ZK EPO 64 Factor Xa inhibitor 64 sunitinib malate 64 Telintra 64 antisense drug 64 Dasatinib 64 talabostat 64 Virulizin R 64 Capesaris 64 midstage trials 64 ONTAK 64 Zolinza 64 HspE7 64 dirucotide 64 nab paclitaxel 64 Triapine R 64 rNAPc2 64 CINTREDEKIN BESUDOTOX 64 optimal dosing 64 TKM ApoB 64 NGX# 64 Fx #A 64 Stimuvax R 64 Sanvar R 64 ancrod 64 Protexia ® 64 RLY# 64 BEMA TM Fentanyl 64 Exherin 64 TOLAMBA 64 zalutumumab 64 HCV protease inhibitors 64 vosaroxin 64 DCCR 64 ALN TTR 64 octreotide acetate 64 BEMA Fentanyl 64 volociximab 64 ISF# 64 Desmoteplase 64 initiate Phase 1b 64 PI3K/Akt pathway inhibitor 64 AeroLEF 64 Novolimus 64 Hedgehog antagonist 64 ThermoDox R 64 systemically administered 64 Vidaza azacitidine 64 bevacizumab Avastin ® 64 histone deacetylase HDAC inhibitor 64 MEK inhibitor RDEA# 64 pharmacodynamic profile 64 fipamezole 64 Sapacitabine 64 SinuNase 64 immunotherapeutic vaccine 64 Alzhemed TM 64 Tarvacin 64 dose cohorts 64 PEGylated interferon 64 drug conjugate 64 Tasimelteon 64 RGB # 64 ponatinib 64 evaluating tivozanib 64 NPC 1C 64 albinterferon alfa 2b 64 trodusquemine 64 brivaracetam 64 Combidex 64 faropenem 64 methylnaltrexone bromide 64 Zenvia ™ 64 ACAPODENE 64 RhuDex ® 64 CYT# potent vascular disrupting 64 Tarceva TM 64 uric acid lowering 64 LHRH antagonist 64 Vilazodone 64 reslizumab 64 Posiphen 64 PREOS 64 dalbavancin 64 alvimopan 64 dose escalation 64 aminolevulinic acid ALA 64 palifosfamide 64 Glufosfamide 64 synthetic retinoid 64 CRLX# 63 Saforis 63 Orazol 63 Immunotherapeutic 63 Tarvacin TM 63 hypoxia activated prodrug 63 Ocrelizumab 63 Xerecept 63 OncoGel 63 dexanabinol 63 NVA# 63 Leukine 63 viral kinetics 63 phase Ib 63 Cloretazine 63 phase 2a 63 ganaxolone 63 Cleviprex TM clevidipine 63 adecatumumab MT# 63 Perifosine 63 oxaliplatin Eloxatin 63 ALN PCS 63 targeting CD# 63 VitiGam 63 ONCONASE 63 investigational monoclonal antibody 63 NXL# 63 Altastaph 63 AZILECT R 63 RSD# 63 adipiplon 63 PEGPH# 63 GGF2 63 Celator 63 Q#IR 63 metaglidasen 63 Pafuramidine 63 MyVax 63 intravenously administered 63 rBChE 63 ZADAXIN ® 63 rhIGF-I/rhIGFBP-3 63 Angiocept 63 RSD# oral 63 Xcellerated T Cells 63 phase IIa 63 PI3K inhibitor 63 GALNS 63 PREOS R 63 DDP# 63 Sudhir Agrawal D.Phil 63 MoxDuo IR 63 R sorafenib tablets 63 Initiates Clinical 63 Methylnaltrexone 63 huC# DM4 63 Elagolix 63 Genasense ® 63 GAMMAGARD 63 Ketotransdel 63 palifermin 63 eprotirome 63 Telatinib 63 visilizumab 63 PRTX 63 Anturol TM 63 PEGylated anti 63 Nanobody ® 63 AAG geldanamycin analog 63 Neupogen ® 63 sorafenib tablets 63 nucleotide analog 63 ThGRF 63 phase IIb study 63 Protectan CBLB# 63 LibiGel ® 63 droxidopa 63 GTC recombinant human 63 Azacitidine 63 pafuramidine 63 Vernakalant 63 antitumor effect 63 sodium thiosulfate STS 63 Chrysalin 63 CRMD# 63 registrational studies 63 Phase IIa trials 63 Onco TCS 63 AzaSite Plus 63 Genasense R oblimersen 63 neratinib 63 Toraymyxin TM 63 Urocidin TM 63 ongoing Phase 1b 63 injectable formulation 63 rhMBL 63 galiximab 63 therapeutic monoclonal antibody 63 interferon gamma 1b 63 pharmacodynamic effects 63 antitumor activity 63 trastuzumab DM1 63 LY# [003] 63 ON #.Na 63 Tocosol Paclitaxel 63 PS# [001] 63 CCX# B 63 Elvitegravir 63 cediranib 63 clevidipine 63 Firazyr 63 Aurexis 63 Inhalation Solution 63 intranasal delivery 63 JP-#/fipamezole 63 Azixa 63 pharmacological chaperone 63 GFT# 63 crizotinib PF # 63 EndoTAG 63 ARIKACE 63 Pralatrexate 63 Nuvion 63 exon skipping 63 Interferon alpha 63 TRX1 63 AERx iDMS 63 Phase Ib 63 Surfaxin LS 63 Initiate Phase 63 Marqibo TM 63 REG1 63 Phase Ib clinical 63 paclitaxel Taxol 63 myeloproliferative disorders 63 Ceflatonin 63 GLP toxicology studies 63 Pertuzumab 63 REBETOL combination therapy 63 relapsed MCL 63 SPRYCEL ® 63 Fludara ® 63 blinatumomab 63 lapatinib Tykerb 63 selective S#P# receptor agonist 63 alpha 2a 63 TransVax TM 63 AZX# 63 TEMODAL 63 histamine dihydrochloride 63 Technosphere Insulin 63 TroVax 63 Aganocide 63 Valortim 63 BEXXAR 63 Fentanyl TAIFUN R 63 Phase Ib clinical trials 63 TLK# 63 ZYBRESTAT 63 INT# [002] 63 tocilizumab 63 dose escalation Phase 63 riociguat 63 Genz # 63 Egrifta 63 Ambrisentan 63 orBec 63 urocortin 2 63 CDK inhibitor 63 MBP# [001] 63 nicotinic alpha 7 63 PROCHYMAL 63 vascular disrupting agent 63 relapsed multiple myeloma 63 cancer neuroendocrine tumor 63 idarubicin 63 AKT inhibitor 63 relapsed ovarian cancer 63 rhThrombin 63 rHuPH# 63 ISIS # 63 cinacalcet HCl 63 Kepivance 63 ADP receptor antagonist 63 novel anticancer 63 maximally tolerated dose 63 Syncria 63 EP #R 63 Actimmune ® 63 APOPTONE 63 URG# 63 CA9 SCAN 63 PrevOnco 63 Fulvestrant 63 UVIDEM 63 TPI ASM8 63 TORISEL 63 Phase 2b trial 63 Rebif ® 63 rilonacept 63 Serdaxin 63 Romiplostim 63 R#/MEM # 63 bazedoxifene 63 DU #b 63 glatiramer acetate 63 CTAP# Capsules 63 HDL Mimetic Peptide 63 MAA submission 63 inhaled formulation 63 maribavir 63 Selective Electrochemical Tumor Ablation 63 GLYX 63 busulfan 63 INTEGRILIN 63 bevacizumab Avastin 63 biologic therapy 63 Clavis Pharma 63 XL# XL# 63 MYDICAR 63 oncolytic virus therapy 63 samalizumab 63 ATL/TV# 63 clinical pharmacology studies 63 DP b# 63 stated Michelle Berrey 62 Carfilzomib 62 Temsirolimus 62 Restanza 62 SinuNase ™ 62 OMP #R# 62 treprostinil 62 Raptiva ® 62 fostamatinib 62 Pemetrexed 62 Phase 1b 62 Troxatyl 62 ORMD 62 TRISENOX 62 Cytolin ® 62 Onalta 62 eritoran 62 Phase 1a clinical 62 HCV protease 62 Xcytrin R 62 Taxotere docetaxel 62 ADVEXIN 62 immunotherapeutic agent 62 paclitaxel poliglumex 62 rituximab Rituxan 62 Mepact 62 ACOMPLIA R 62 THALOMID 62 Erbitux cetuximab 62 PEG PAL 62 vemurafenib 62 novel peptide 62 novel histone deacetylase 62 edoxaban 62 BCX# 62 ZD# [001] 62 Alpharadin 62 Phenoptin 62 SERMs 62 Aclidinium 62 aflibercept 62 bendamustine 62 Advexin 62 postoperative ileus POI 62 tecarfarin 62 Homspera 62 paclitaxel Taxol ® 62 telaprevir VX 62 ESBA# 62 IND submission 62 insulin sensitizing 62 Pathway Inhibitor 62 Theratope 62 GW# [003] 62 isoform selective 62 small molecule thrombopoietin 62 elesclomol 62 EndoTAGTM 1 62 NV1FGF 62 immune modulatory 62 BioNumerik 62 DAVANAT ® 62 Phase IIb trial 62 diabetic neuropathic pain 62 rALLy clinical trial 62 PEGylated Fab fragment 62 Preclinical studies suggest 62 anti leukemic 62 PANVAC VF 62 Granulocyte Colony Stimulating Factor 62 Alocrest 62 dasatinib Sprycel 62 tafamidis 62 imetelstat 62 initiated Phase Ib 62 daclizumab 62 BiTE 62 ApoB SNALP 62 SCIB1 62 personalized immunotherapy 62 plasma kallikrein inhibitor 62 vascular disrupting agents 62 Anthim 62 hormone LHRH antagonist 62 immune modulating 62 optimal dosing regimens 62 humanised monoclonal antibody 62 Elocalcitol 62 palonosetron 62 Clonicel 62 Androxal ® 62 dosage regimens 62 XOMA 3AB 62 pharmacokinetic PK 62 Sulonex TM 62 renin inhibitor 62 G#DT 62 metastatic castration resistant 62 evaluating satraplatin 62 bendamustine HCl 62 immunomodulatory 62 Panzem NCD 62 dextromethorphan quinidine 62 Vascular Wrap TM 62 Naproxcinod 62 Zelrix 62 Unit Dose Budesonide 62 telomerase therapeutic 62 EFAPROXYN 62 Voreloxin 62 cinacalcet 62 ZEVALIN ® 62 veltuzumab 62 CD3 monoclonal antibody 62 QRxPharma 62 Targretin capsules 62 Aurora kinase 62 Ereska 62 gemcitabine cisplatin 62 compound INCB# 62 budesonide foam 62 photoprotective drug 62 NEUMUNE 62 IRESSA 62 Vaprisol 62 Revimmune 62 ALGRX 62 Rasagiline 62 Azilect ® 62 cathepsin K inhibitor 62 CDP# 62 outlicensing 62 VNP#M 62 standard chemotherapy regimen 62 Ozarelix 62 Evoltra TM 62 ENMD 62 pharmacodynamic markers 62 ELND# 62 OMAPRO 62 Intravail R 62 Pivotal Phase III 62 ICA # 62 DR Cysteamine 62 IMiDs ® 62 ACAPODENE R 62 SARMs 62 mTOR inhibition 62 leading oral taxane 62 HDL Selective Delipidation 62 Chemokine 62 brentuximab vedotin 62 lesinurad 62 orally inhaled 62 direct thrombin inhibitor 62 sulodexide 62 AZD# 62 inhibit metastasis 62 #D#C# 62 TAXOTERE R 62 Phase 2a clinical trials 62 TG# [003] 62 nonclinical studies 62 GnRH antagonist 62 anticancer activity 62 MyVax ® 62 non nucleoside inhibitor 62 prostate cancer AIPC 62 Evoltra ® 62 tyrosine kinase inhibitor 62 darapladib 62 BRIM2 62 HDAC Inhibitor 62 Reverset 62 multi kinase inhibitor 62 DAVANAT R 62 SUTENT ® 62 Diamyd ® 62 Omacetaxine mepesuccinate 62 Bendamustine 62 Nexavar sorafenib 62 trastuzumab Herceptin ® 62 preclinical pharmacokinetic 62 aleglitazar 62 vismodegib 62 Anavex #-# 62 Canvaxin 62 tivozanib 62 olaparib 62 Ophena 62 intradermal injection 62 Natalizumab 62 Aviptadil 62 peripherally acting 62 Hsp# Inhibitor 62 Ventavis ® 62 NEUGENE 62 Liposomal 62 TriRima 62 Acapodene 62 Prodarsan ® 62 Spiegelmer ® 62 MAXY VII 62 refractory chronic lymphocytic 62 apremilast 62 Phase IIa trial 62 polymerase inhibitor 62 ThermoDox ® 62 fidaxomicin 62 dose escalation clinical 62 RNAi therapeutic targeting 62 TBC# 62 Noxafil 62 Taxotere chemotherapy 62 Lupuzor 62 telaprevir dosed 62 MYDICAR ® 62 Zingo TM 62 LEVADEX ™ 62 AMEVIVE 62 EVIZON TM 62 luteinizing hormone releasing 62 PROVENGE sipuleucel T 62 sunitinib Sutent 62 Cloretazine R VNP#M 62 Debio 62 glufosfamide 62 Resten NG 62 Telbivudine 62 antisense inhibitor 62 anidulafungin 62 radezolid 62 anti angiogenic agent 62 sunitinib 62 dasatinib Sprycel ® 62 dose cohort 62 tasimelteon 62 ThermoDox 62 IV APAP 62 Initiates Enrollment 62 Curaxin 62 mecamylamine 62 Triolex 62 OPAXIO 62 SPRIX ® 62 terlipressin 62 Aplidin R 62 pegfilgrastim 62 M Vax 62 oral anticoagulant 62 fenretinide 62 subcutaneous RELISTOR 62 milatuzumab 62 ZADAXIN 62 beta 1a 62 Catena ® 62 cangrelor 62 Stimuvax 62 rhIGFBP 3 62 kinase inhibitor 62 Luteinizing Hormone Releasing Hormone 62 Phase 2b study 62 2A receptor agonist 62 vilazodone 62 TASKi3 62 RECOTHROM R 62 octreotide 62 Ecallantide 62 siRNA therapeutics 62 Cethromycin